$AURX

$1.21 +$0.10 (9.01%) Close

$AURX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 48.4M shares outstanding

Who owns AURX?

By type of holder

Institutions 0.0% Insiders 41.5% Everyone else 58.5%

Concentration Top 6 holders own 42.0%

Sheedy Charles E 23.9% · Pittman Scott M. 11.6%

Institutional ownership

0.0%

0.0 pts vs last qtr

Institutional holders

0 vs last qtr

Net shares bought

by institutions in Q2 2026

New / sold out

0 / 0

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

No 13F manager has reported this stock in the last 8 quarters.

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026

None.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Nuo Therapeutics Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2017–FY2021

+106.9%

+19.93% a year

Each share's claim on the business

−51.7%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

$471 vs $458K

over 5 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

No 13F manager reports holding AURX.

Super Investors

Investment managers reporting AURX on Form 13F

No 13F manager reports holding AURX yet.

Institutional Funds

Mutual funds and ETFs reporting AURX on Form N-PORT; together they hold 0.0% of the company

No fund reports holding AURX yet.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
SC Sheedy Charles E Insider	11.6M	23.91%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company23.910% Sheedy Charles E's insider activity →
PS Pittman Scott M. 5%+ holder 13D · 11.6%	5.6M	11.62%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company11.620% Disclosed stake13D · 11.6% View the 13D/G filing →

Sheedy Charles E

Insider

11.6M

% of company

23.91%

Change vs last qtr

—

Held since

—

Pittman Scott M.

5%+ holder13D · 11.6%

5.6M

% of company

11.62%

Change vs last qtr

—

Held since

—

4 more holders behind a free account

See every insider and 5%+ holder of Nuo Therapeutics Inc.

Comments